Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 29:14:807909.
doi: 10.3389/fnagi.2022.807909. eCollection 2022.

Therapeutic Devices for Motor Symptoms in Parkinson's Disease: Current Progress and a Systematic Review of Recent Randomized Controlled Trials

Affiliations
Review

Therapeutic Devices for Motor Symptoms in Parkinson's Disease: Current Progress and a Systematic Review of Recent Randomized Controlled Trials

Joji Fujikawa et al. Front Aging Neurosci. .

Abstract

Background: Pharmacotherapy is the first-line treatment option for Parkinson's disease, and levodopa is considered the most effective drug for managing motor symptoms. However, side effects such as motor fluctuation and dyskinesia have been associated with levodopa treatment. For these conditions, alternative therapies, including invasive and non-invasive medical devices, may be helpful. This review sheds light on current progress in the development of devices to alleviate motor symptoms in Parkinson's disease.

Methods: We first conducted a narrative literature review to obtain an overview of current invasive and non-invasive medical devices and thereafter performed a systematic review of recent randomized controlled trials (RCTs) of these devices.

Results: Our review revealed different characteristics of each device and their effectiveness for motor symptoms. Although invasive medical devices are usually highly effective, surgical procedures can be burdensome for patients and have serious side effects. In contrast, non-pharmacological/non-surgical devices have fewer complications. RCTs of non-invasive devices, especially non-invasive brain stimulation and mechanical peripheral stimulation devices, have proven effectiveness on motor symptoms. Nearly no non-invasive devices have yet received Food and Drug Administration certification or a CE mark.

Conclusion: Invasive and non-invasive medical devices have unique characteristics, and several RCTs have been conducted for each device. Invasive devices are more effective, while non-invasive devices are less effective and have lower hurdles and risks. It is important to understand the characteristics of each device and capitalize on these.

Keywords: Parkinson’s disease; freezing of gait (FOG); gait; invasive medical devices; non-invasive medical device; stimulation; tremor.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Body parts the medical devices are applied to. The stimulation targets of each device are shown in this figure.
FIGURE 2
FIGURE 2
Flow diagram of the study selection process in the systematic review. This diagram shows how to search for studies in a systematic review. The numbers in parentheses show the breakdown of the number of search hits, with PubMed and Scopus listed in that order.

References

    1. Agari T., Date I. (2012). Spinal cord stimulation for the treatment of abnormal posture and gait disorder in patients with Parkinson’s disease. Neurol. Med. Chir. 52 470–474. 10.2176/nmc.52.470 - DOI - PubMed
    1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G. M., et al. (2000). Inflammation and Alzheimer’s disease. Neurobiol. Aging 21 383–421. 10.1016/s0197-4580(00)00124-x - DOI - PMC - PubMed
    1. Akiyama H., Nukui S., Akamatu M., Hasegawa Y., Nishikido O., Inoue S. (2017). Effectiveness of spinal cord stimulation for painful camptocormia with Pisa syndrome in Parkinson’s disease: a case report. BMC Neurol. 17:148. 10.1186/s12883-017-0926-y - DOI - PMC - PubMed
    1. Anderson T. J., MacAskill M. R. (2013). Eye movements in patients with neurodegenerative disorders. Nat. Rev. Neurol. 9 74–85. 10.1038/nrneurol.2012.273 - DOI - PubMed
    1. Aquino C. C., Duffley G., Hedges D. M., Vorwerk J., House P. A., Ferraz H. B., et al. (2019). Interleaved deep brain stimulation for dyskinesia management in Parkinson’s disease. Mov. Disord. 34 1722–1727. 10.1002/mds.27839 - DOI - PMC - PubMed

LinkOut - more resources